-
Researchers from Harvard Medical Schools teaching hospital in Boston decided to test if they could encourage physicians to switch appropriate patients from intravenous (IV) to oral (PO) medications.
-
Abbott Laboratories is not backing down from its decision to increase the price of ritonavir (Norvir) by 500% monthly for patients who take 100 mg a day. Ritonavir is used in almost all protease inhibitor combinations for treating HIV infection.
-
ViaCell will begin to enroll patients in a Phase I/II clinical trial of CB001, a highly purified population of stem cells that has been isolated from umbilical cord blood and multiplied using the companys patented Selective Amplification technology.
-
-
Stokes MJ. Soy and menopausal symptoms. Altern Med Alert 2004;7(5):49-55.
-
Greenfield RH. Stress and multiple sclerosis. Altern Med Alert 2004;7(5):59-60.
-
If an 11-year-old girl comes to your ED with a radius-ulnar fracture, she is X-rayed, casted, and discharged home a minor injury with minor inconveniences.
-
Here are key recommendations from the Atlanta-based Centers for Disease Control and Prevention guidance for preventing and controlling influenza in health care facilities:
-
Editors note: This is the second of a two-part series on improving care of obese patients in the ED. This months story addresses complications of surgical treatment for morbid obesity you may be seeing in your ED. Last month, we covered special considerations for assessment and supplies.
-
The Havasupai Indian tribe of northwestern Arizona, and some of its individual members, have filed two federal lawsuits seeking a total of $75 million in damages against Arizona State University (ASU), the Arizona Board of Regents, and three university researchers, claiming that blood samples taken from tribe members as part of a diabetes study were destroyed, lost, or used in studies of schizophrenia, inbreeding, and population migration without the donors consent.